Search for: "Alan W. Davis v. State" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Dec 2009, 3:06 am
Miller (Lewis and Clark), Judith V. [read post]
17 Jun 2022, 2:09 pm by admin
  Ever since the United States Supreme Court decided Daubert v. [read post]
7 Apr 2024, 9:05 pm by renholding
For many business economists and legal academics, the purpose of any business organization is simply stated: to maximize profits. [read post]
10 May 2014, 6:55 am by Yishai Schwartz
Ben also posted video from a recent “Munk debate” on state surveillance. [read post]
9 Aug 2011, 10:06 am by Roshonda Scipio
(RES) TZ 2 SP33 2011 Civil Rights With all deliberate speed : implementing Brown v. [read post]
29 Dec 2017, 7:34 am by Ben
In the UK in FAPL v BT [2017] Mr Justice Arnold concluded that the High Court has the jurisdiction to make an order against an access provider that would require the ISP to block access not to a website but rather streaming servers giving unauthorised access to copyright content - 'live' blocking. [read post]
The SEC explained: [W]e believe that NEPA requires and authorizes the Commission to consider the promotion of environmental protection along with other considerations in determining whether to require affirmative disclosures by registrants under the Securities Act and the Securities and Exchange Act . . . . [read post]
16 Sep 2009, 1:47 pm
(Braintree, MA; Alan Alderson, President) Amirah, Inc. [read post]
8 Oct 2010, 2:14 pm by Roshonda Scipio
Publishers, c2009.Civil ProcedureKF8841 .G59 2009The Glannon guide to civil procedure : learning civil procedure through multiple-choice questions and analysis / Joseph W. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]